RBC begins coverage of Restore Medical at outperform

RBC Capital Markets analyst Phil Nalbone began coverage of Restore Medical, Inc. with an outperform rating, speculative risk, and a 12-month price target of $11. The company's unique Pillar inserts represent a minimally invasive treatment for snoring and mild to moderate sleep apnea. Shares of the St. Paul, Minn.-based medical device company were up 43 cents, or 5.84%, at $7.79 on volume of 54,502 shares versus the three-month running average of 92,896 shares. (Nasdaq: REST)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.